Insights

We’re acknowledged for our strong market insight and technical know-how

Insights

Regulation of GMOs: time to modify the law?

26 August 2021
Read more
Insights

Illumina Cambridge Limited v Latvia MGI Tech SIA & Others – the “chocolate teapot” theory

21 April 2021
Read more
Insights

Regeneron v Kymab: UK Supreme Court rules against Regeneron in landmark patent claim sufficiency judgment

8 September 2020
Read more
Insights

Data protection: guidance for publishers

27 July 2020
Read more
News

The European Commission postpones Medical Devices Regulation

3 July 2020
Read more
Insights

Cambridge team has its eye on the ones to watch

3 March 2020
Read more
Insights

New guidance on the classification of software as medical devices

21 February 2020
Read more
Insights

Brexit and the life sciences sector – what are the impacts?

14 February 2020
Read more
Insights

Contingency legislation covering regulation of medicines, medical devices and clinical trials in a no deal scenario

11 March 2019
Read more
Insights

Brexit no-deal technical notices – implications for the life sciences sector

18 October 2018
Read more
Insights

Government’s response to Accelerated Access Review

22 December 2017
Read more
Insights

Genesis 2017: Rachel Bradley takes part in panel discussion on building trust in digital health

15 December 2017
Read more